SCHEMBL7389965

SCHEMBL7389965

CCCNCCCCCCCCCCCC(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 4/20 0.55
SOAT1 P35610 2/20 0.48
MEN1 O00255 1/20 0.48
FAAH O00519 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 1/20 0.48
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
HDAC6 Q9UBN7 1/20 0.43
S1PR2 O95136 5/20 0.42
S1PR4 O95977 5/20 0.42
S1PR1 P21453 5/20 0.42
S1PR3 Q99500 5/20 0.42
S1PR5 Q9H228 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065981 1.00 PAOX (0.55) PAOXSOAT1MEN1FAAHTP53
SCHEMBL28375298 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL16620178 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL28928375 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL23929253 0.91 SOAT1 (0.53) PAOXSOAT1MEN1FAAHTP53
SCHEMBL28816812 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL28888916 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL25185288 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53
SCHEMBL22834949 0.91 SOAT1 (0.53) PAOXSOAT1MEN1FAAHTP53
SCHEMBL28164599 0.91 SOAT1 (0.59) PAOXSOAT1MEN1FAAHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1252178-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-10-30 EP disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed